These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 15977236

  • 21. Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects.
    Monno L, Scudeller L, Brindicci G, Saracino A, Punzi G, Chirianni A, Lagioia A, Ladisa N, Lo Caputo S, Angarano G.
    Antiviral Res; 2009 Aug; 83(2):118-26. PubMed ID: 19549585
    [Abstract] [Full Text] [Related]

  • 22. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
    Capiluppi B, Saracco A, Gianotti N, Mussini C, Butini L, Tomasoni L, De Gennaro M, Rizzolo L, Monolo G, Cargnel A, Moioli C, Arici C, Portelli V, Rizzardini G, Lazzarin A, Tambussi G.
    J Biol Regul Homeost Agents; 2002 Aug; 16(1):73-8. PubMed ID: 12003179
    [Abstract] [Full Text] [Related]

  • 23. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [Abstract] [Full Text] [Related]

  • 24. [Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province].
    Yang K, Li JY, Bao ZY, Li HP, Li L, Zhuang DM, Wang Z, Li H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):351-5. PubMed ID: 16053762
    [Abstract] [Full Text] [Related]

  • 25. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L, Stuyver L, Van Houtte M, Butel C, Delaporte E, Peeters M.
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [Abstract] [Full Text] [Related]

  • 26. The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in south India.
    Kandathil AJ, Kannangai R, Abraham OC, Rupali P, Pulimood SA, Verghese VP, Grant P, Pillay D, Sridharan G.
    Int J STD AIDS; 2009 Aug; 20(8):522-6. PubMed ID: 19625581
    [Abstract] [Full Text] [Related]

  • 27. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M, Carmona R, Pérez-Alvarez L, Cilla G, Suarez MD, Delgado E, Contreras G, Corral J, de Goicoetxea MJ, Medrano L, Lezaún MJ, Nájera R, Spanish Group for Antiretroviral Resistance Studies in Basque Country.
    J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
    [Abstract] [Full Text] [Related]

  • 28. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
    Jullaksorn D, Boonchawalit S, Uttiyoung J, Soonthornsata B, Yowang A, Krathong N, Chautrakul S, Ikuta K, Roobsoong A, Kanitvittaya S, Sawanpanyalert P, Kameoka M.
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
    [Abstract] [Full Text] [Related]

  • 29. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, Corral A, Heneine W, de Mendoza C, García-Lerma JG.
    AIDS; 2007 Nov 30; 21(18):2503-11. PubMed ID: 18025887
    [Abstract] [Full Text] [Related]

  • 30. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
    Paraschiv S, Otelea D, Baicus C, Tinischi M, Costache M, Neaga E.
    Int J Infect Dis; 2009 Jan 30; 13(1):81-9. PubMed ID: 18632295
    [Abstract] [Full Text] [Related]

  • 31. Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.
    Avi R, Huik K, Sadam M, Karki T, Krispin T, Ainsalu K, Paap P, Schmidt J, Nikitina N, Lutsar I.
    J Med Virol; 2009 Jun 30; 81(6):953-8. PubMed ID: 19382254
    [Abstract] [Full Text] [Related]

  • 32. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.
    Sá-Ferreira JA, Brindeiro PA, Chequer-Fernandez S, Tanuri A, Morgado MG.
    Transfusion; 2007 Jan 30; 47(1):97-102. PubMed ID: 17207236
    [Abstract] [Full Text] [Related]

  • 33. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J, Weber J, Machala L, Reinis M, Linka M, Brůcková M, Vandasová J, Stanková M, Konvalinka J.
    Acta Virol; 2005 Jan 30; 49(1):29-36. PubMed ID: 15929396
    [Abstract] [Full Text] [Related]

  • 34. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.
    Bon I, Gibellini D, Borderi M, Alessandrini F, Vitone F, Schiavone P, Re MC.
    J Clin Virol; 2007 Apr 30; 38(4):313-20. PubMed ID: 17306618
    [Abstract] [Full Text] [Related]

  • 35. Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.
    Lwembe R, Ochieng W, Panikulam A, Mongoina CO, Palakudy T, Koizumi Y, Kageyama S, Yamamoto N, Shioda T, Musoke R, Owens M, Songok EM, Okoth FA, Ichimura H.
    J Med Virol; 2007 Jul 30; 79(7):865-72. PubMed ID: 17516531
    [Abstract] [Full Text] [Related]

  • 36. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
    Escoto-Delgadillo M, Vázquez-Valls E, Ramírez-Rodríguez M, Corona-Nakamura A, Amaya-Tapia G, Quintero-Pérez N, Panduro-Cerda A, Torres-Mendoza BM.
    HIV Med; 2005 Nov 30; 6(6):403-9. PubMed ID: 16268822
    [Abstract] [Full Text] [Related]

  • 37. [Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].
    Si XF, Huang HL, Wei M, Guan Q, Song YH, Ma PF, Quan Y, Xing H, Shao YM.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec 30; 18(4):308-11. PubMed ID: 15650776
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
    Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M, Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.
    Clin Infect Dis; 2005 Feb 01; 40(3):468-74. PubMed ID: 15668873
    [Abstract] [Full Text] [Related]

  • 39. Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDS.
    Winters MA, Baxter JD, Mayers DL, Wentworth DN, Hoover ML, Neaton JD, Merigan TC.
    Antivir Ther; 2000 Mar 01; 5(1):57-63. PubMed ID: 10846594
    [Abstract] [Full Text] [Related]

  • 40. [Background study of HIV-1 drug resistant mutations in treatment-naive patients in liaoning province].
    Han XX, Zhang M, Dai D, Lu C, Zhang ZN, Liu J, Wang YN, Jiang YJ, Shang H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct 01; 28(5):632-6. PubMed ID: 17121220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.